Blood Thinners and Regional Anesthesia: A Summary of ASRA’s Fifth-Edition Guidelines
Spinal and epidural anesthesia, and deep nerve blocks, are used every day for joint replacement, cesarean delivery, labor, and many other procedures. Many of these patients also take medications that reduce blood clotting. The concern is bleeding around the spinal cord or a deep nerve. A spinal epidural hematoma is extremely rare, but it can press on the spinal cord and cause permanent weakness or paralysis. The American Society of Regional Anesthesia and Pain Medicine (ASRA) has now published its fifth-edition guidelines, by Kopp and colleagues, online ahead of print in Regional Anesthesia and Pain Medicine.
This summary is based on the published abstract and does not reproduce specific drug timing intervals, which should be taken from the full guideline. Read the abstract on PubMed
What the authors set out to do
The fifth edition reviews evidence published since the 2018 edition and gives guidance to help clinicians avoid bleeding complications in patients receiving antithrombotic (blood-thinning) or thrombolytic (clot-dissolving) therapy.
How the guidance was developed
- It uses a method similar to earlier editions but is reorganized and significantly condensed.
- It refers readers to earlier editions for detailed methods, trials, case series, and pharmacology.
- Each recommendation notes how it changed from the previous edition.
Because spinal hematoma is so rare, large randomized trials are impossible. Where evidence is limited, the guidance takes a cautious approach.
What is new or emphasized
- An “antihemorrhagic” approach: where evidence is limited, conservative times are proposed for stopping blood thinners before a neuraxial or deep block.
- New dose terms: “low dose” and “high dose” replace “prophylactic” and “therapeutic.” The same high dose might treat a clot in one patient and prevent one in another; bleeding risk follows the dose, not the label.
- Drug-specific lab tests: the guidelines suggest when these assays may help guide practice.
Limitations
- Many recommendations rest on case reports, pharmacology, and consensus, as the authors acknowledge.
- Stopping a blood thinner earlier lowers bleeding risk but can raise clotting risk, so individual judgment is still needed.
- The condensed document is best used with earlier editions.
- Hospitals often adapt national guidance into local protocols.
- Volume and page numbers were not yet assigned when this summary was prepared.
Safety takeaways
- Take a complete medication history, including every blood thinner, the dose, and the time of the last dose.
- Think in terms of dose, not only why a drug was prescribed.
- Use the current edition and make sure protocols reflect it.
- Coordinate with the prescribing clinician when pausing a blood thinner.
- Plan catheter removal and restarting medication, since timing matters at both steps.
- Watch for warning signs. New back pain, numbness, or leg weakness after a neuraxial procedure calls for prompt evaluation.
Reference
- Kopp SL, Vandermeulen E, McBane RD, Perlas A, Leffert L, Horlocker T. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition). Reg Anesth Pain Med. 2025 Oct 17:rapm-2024-105766. Online ahead of print. DOI: 10.1136/rapm-2024-105766. PMID: 39880411. Abstract: https://pubmed.ncbi.nlm.nih.gov/39880411/
Related: Regional Anesthesia and Nerve Block Cases
This article is educational information, not legal or medical advice.
Back to Blog